Frontier Biotechnologies Inc. (SHA:688221)
China · Delayed Price · Currency is CNY 27.73
+0.40 (1.46%)
At close: Jul 3, 2026
Frontier Biotechnologies Market Cap
Frontier Biotechnologies has a market cap or net worth of 10.39 billion as of July 2, 2026. Its market cap has increased by 180.38% in one year.
Market Cap
10.39B
Enterprise Value
10.13B
Revenue
392.19M
Ranking
n/a
PE Ratio
3,000.09
Stock Price
27.73
Market Cap Chart
Since October 28, 2020, Frontier Biotechnologies's market cap has decreased from 10.76B to 10.39B, a decrease of -3.47%. That is a compound annual growth rate of -0.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 10.39B | 53.63% |
| Dec 31, 2025 | 6.76B | 84.94% |
| Dec 31, 2024 | 3.66B | -1.61% |
| Dec 29, 2023 | 3.72B | -42.53% |
| Dec 30, 2022 | 6.47B | -3.33% |
| Dec 31, 2021 | 6.69B | -3.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Henan Lingrui Pharmaceutical | 11.25B |
| Zhejiang Medicine | 11.18B |
| Shanghai Shyndec Pharmaceutical | 11.04B |
| Guangdong Taienkang Pharmaceutical | 10.97B |
| Zhejiang Jingxin Pharmaceutical | 10.85B |
| Yantai Dongcheng Pharmaceutical Group | 10.54B |
| Zhejiang CONBA Pharmaceutical | 10.15B |
| Mayinglong Pharmaceutical Group | 9.59B |